Skip to main content
OpenTrials

Clinical trial condition

Goiter

Explore clinical trials studying Goiter. Study availability and eligibility vary by location and protocol.

243 public trials 66 recruiting studies
Refine in advanced search Browse all conditions

Goiter trial results

Completed

Rituximab (RTX) Therapy in Patients With Active TAO

NCT02378298

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Center for Endocrinology and Metabolism, Sahlgrenska University Hospital Gothenburg, Sweden
  • MedTech West, Institute of Neuro Science and Physiology, Department for Clinical Neuro Science and Rehabilitation, Sahlgrenska Academy, University of Gothenburg Gothenburg, Sweden
  • Department of Ophthalmology, Sahlgrenska University Hospital/Mölndal Mölndal, Sweden
  • Department of Rheumatology, Sahlgrenska University Hospital/Mölndal Mölndal, Sweden
View Trial Details
Completed

Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism

NCT01611896

Conditions
Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +8 more
Locations
  • Department of Endocrinology and Gastroenterology, Bispebjerg Hospital Copenhagen, Denmark
  • Department of Medical Endocrinology, Rigshospitalet Copenhagen, Denmark
  • Department of Endocrinology, Hospital of Southwest Denmark Esbjerg, Denmark
  • Department of Medicine, Gentofte Hospital Gentofte Municipality, Denmark
View Trial Details
Completed

A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease

NCT05331300

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +19 more
Locations
  • Site AU05 Hurstville, New South Wales, Australia
  • Site AU03 Brisbane, Queensland, Australia
  • Site AU01 Melbourne, Victoria, Australia
  • Site HK01 Shatin, Hong Kong
View Trial Details
Completed

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

NCT01868997

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations
  • Jules Stein Eye Institute at UCLA Los Angeles, California, United States
  • University of Denver Aurora, Colorado, United States
  • Emory University Department of Ophthalmology Atlanta, Georgia, United States
  • University of Iowa Hospitals and Clinics, Department of Ophthalmology Iowa City, Iowa, United States
View all 15 locations
View Trial Details
Completed

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

NCT03298867

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations
  • Macro, Llc Beverly Hills, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • The Lennar Foundation Medical Coral Gables, Florida, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

NCT04583735

Conditions
Autoimmune Diseases, Behavior, Bronchial Diseases, +25 more
Locations
  • The Private Practice of Raymond Douglas Beverly Hills, California, United States
  • Perlman Medical Offices / UCSD La Jolla, California, United States
  • MACRO Trials Los Angeles, California, United States
  • Univ of Colorado Dept of Ophthalmology Aurora, Colorado, United States
View Trial Details

Related conditions